News Release

Doctors test chest pain medication to treat hot flashes

Peer-Reviewed Publication

University of California - San Francisco

Women have long searched for remedies for the bothersome hot flashes that often come with menopause. 

In a novel investigation, researchers at UC San Francisco tested the benefits of continuously wearing a nitroglycerin patch – an established treatment for chest pain from coronary artery disease – for menopausal women experiencing at least seven hot flashes a day. Unlike most treatments for hot flashes that target brain mechanisms, nitroglycerin works on blood vessels throughout the body. 

The results were mixed. While women did experience short-term improvements in moderate to severe hot flashes, the benefits of nitroglycerin compared to placebo did not extend past 12 weeks. Some women also experienced side effects, like headaches.

The paper publishes June 5, 2023 in JAMA Internal Medicine

“Nitroglycerin has been used for decades to treat chest pain in patients with coronary disease because it can increase blood flow to the heart when used for only 12 hours at a time,” said lead author Alison J. Huang, MD, an internal medicine physician at UCSF Health and clinical epidemiologist.
“But lab studies suggested that if nitroglycerin is used continuously, it could prevent or suppress the type of rapid, increased blood flow under the skin that causes sensations of heat and flushing during hot flashes during menopause,” she said. “In this line of research, we repurposed a medication that has been used for close to a century for a different indication.” 

Temperature flare: common and uncomfortable 

Medically known as vasomotor symptoms, intense flushing and sweating are among the most common hallmarks of menopause, occurring in more than two-thirds of menopausal women in the U.S. and causing discomfort and disruption that can last for years. 

Hormone therapy can be highly effective at reducing or suppressing these symptoms, but there are potential risks to long-term estrogen use, including risk of some cancers, heart disease, stroke or dementia. As a result, many women have clamored for non-hormonal treatments that may pose fewer long-term health risks. So far, though, few non-hormonal medications have been found effective. 

Almost all past non-hormonal treatment approaches have focused on brain mechanisms that were thought to trigger hot flashes. But researchers at UCSF decided to focus on what happens in women’s blood vessels during a hot flash. 

They enrolled 141 women between 40 and 62 years old who were in either late menopausal transition or postmenopausal, and randomized them to wear either a nitroglycerin or a placebo patch for 24 hours per day. The women recorded their hot flashes at five and 12 weeks. The randomized, placebo-controlled, and double-blinded design is the gold standard for testing a clinical intervention.  

“It could be that the beneficial effects of nitroglycerin wore off over time,” Huang said. 

“The bottom line is that our study doesn't allow us to recommend nitroglycerin skin patches as a strategy for consumers to suppress hot flashes in the long term,” she said. “But our study suggests that there may be promise in this overall approach to treating a common condition in midlife women. The menopause field is still lacking in effective treatment approaches that don’t involve hormones.”  

Co-authors: Steven R. Cummings, MD, MPH; Peter Ganz, MD; Michael Schembri, BA; Harini Raghunathan, BS, MS; Eric Vittinghoff, PhD; and Deborah Grady, MD, MPH, all from UCSF. Cummings is also with the California Pacific Medical Center Research Institute, and Carolyn J. Gibson, PhD, is from the San Francisco VA Health Care System.  

Funding: The FRAN trial was supported by National Institute on Aging (grant R01AG050588). Huang was also supported by a NIA grant (K24AG068601). For further disclosures, please see the paper.  


About UCSF Health: UCSF Health is recognized worldwide for its innovative patient care, reflecting the latest medical knowledge, advanced technologies and pioneering research. It includes the flagship UCSF Medical Center, which is a top-ranked specialty hospital, as well as UCSF Benioff Children’s Hospitals, with campuses in San Francisco and Oakland, Langley Porter Psychiatric Hospital and Clinics, UCSF Benioff Children’s Physicians and the UCSF Faculty Practice. These hospitals serve as the academic medical center of the University of California, San Francisco, which is world-renowned for its graduate-level health sciences education and biomedical research. UCSF Health has affiliations with hospitals and health organizations throughout the Bay Area. Visit Follow UCSF Health on Facebook or on Twitter


Follow UCSF | | |


Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.